期刊文献+

肝细胞癌样影像特征病人的危险因素分析

Analysis of risk factors for HCC-like imaging feature of primary liver cancer
下载PDF
导出
摘要 目的 研究术前影像学诊断为肝细胞癌(hepatocellular carcinoma, HCC)的病人术后病理诊断为肝内胆管癌(intrahepatic cholangiocarcinoma, ICC)和混合型肝细胞胆管癌(combined hepatocellular-cholangiocarcinoma, cHCC-ICC)的比例及其危险因素。方法 纳入华中科技大学同济医学院附属同济医院和武汉科技大学附属天佑医院两中心2016年1月至2021年12月术前HCC影像学特征的所有病人。采用单因素和多因素logistic回归分析确定HCC样影像特征病人的独立危险因素。结果 共纳入2 402例术前被影像检查诊断为HCC的病人,通过对比术后病理结果发现其中111例(4.6%)病人确诊为ICC(66例)或cHCC-ICC(45例)。经单因素和多因素分析后,女性、甲胎蛋白(AFP)≤400μg/L、糖类抗原(CA)19-9>37 kU/L、病毒感染性肝炎、无肝硬化和轻度肝硬化、低分化、以及肿瘤最大径≤5 cm是HCC样影像特征的独立危险因素。结论 对于具有HCC样影像特征高危因素的人群,提高其术前诊断性是必要的。 Objective To explore the clinical features of patients with hepatocellular carcinoma(HCC)by preoperative imaging examination and examine the proportion and risk factors of ICC or combined hepatocellular-cholangiocarcinoma(cHCC-ICC)patients by postoperative pathology.Methods All patients with preoperative HCC imaging features from Tongji Hospital and Tianyou Hospital between 2016 and 2021 were recruited.Univariate and multivariate Logistic regression analyses were employed for identifying the independent risk factors of HCC-like imaging features.Results A total of 2402 patients with preoperative HCC imaging features were included.There were 111 patients(4.6%)with ICC(n=66)or cHCC-ICC(n=45)confirmed on pathological examination.Univariate and multivariate analyses revealed that females,alpha-fetoprotein(AFP)≤400μg/L,CA19-9>37 kU/L,viral-infected hepatitis,non/mild cirrhosis,low differentiation and nodules with the largest diameter≤5 cm were the independent risk factors of HCC-like imaging patterns.Conclusion It is imperative to improve preoperative diagnostics for patients with high-risk factors of HCC-like imaging patterns.
作者 何正为 王超 杨振华 丹增阿旺 李勇 刘赋斌 史佳宇 次仁平措 袁宵寅 吴成宪 兰润虎 郭玲 姜雪薇 沈亚琪 张斌豪 He Zhengwei;Wang Chao;Yang Zhenhua;Danzeng Awang;Li Yong;Liu Fubin;Shi Jiayu;Ciren Pingcuo;Yuan Xiaoyin;Wu Chengxian;Lan Runhu;Guo Ling;Jiang Xuewei;Shen Yaqi;Zhang Binhao(Division of Hepato-pancreato-biliary Surgery,Tianyou Hospital,Wuhan University of Science&Technology,Hubei Wuhan 430064,China;Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science&Technology,Hubei Wuhan 430030,China;Department of Radiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science&Technology,Hubei Wuhan 430030,China)
出处 《腹部外科》 2023年第3期210-216,共7页 Journal of Abdominal Surgery
基金 湖北省陈孝平科技发展基金会(CXPJJH121001-2021004,CXPJJH122005-19)。
关键词 肝细胞癌 肝内胆管癌 混合型肝细胞胆管癌 肝细胞癌样影像特征 Hepatocellular carcinoma Intrahepatic cholangiocarcinoma Combined hepatocellular-cholangiocarcinoma HCC-like imaging feature
  • 相关文献

参考文献5

二级参考文献69

  • 1Cheng Zhou,Yuanfei Peng,Kaiqian Zhou,Lan Zhang,Xiangyu Zhang,Lei Yu,Jie Hu,Feiyu Chen,Shuangjian Qiu,Jian Zhou,Jia Fan,Zhenggang Ren,Zheng Wang.Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma[J].Hepatobiliary Surgery and Nutrition,2019,8(1):19-28. 被引量:27
  • 2Tianfu Wen,Chen Jin,Antonio Facciorusso,Matteo Donadon,Ho-Seong Han,Yilei Mao,Chaoliu Dai,Shuqun Cheng,Bixiang Zhang,Baogang Peng,Shunda Du,Changjun Jia,Feng Xu,Jie Shi,Juxian Sun,Peng Zhu,Satoshi Nara,JMichael Millis,Qiu Li,Weixia Chen,Wusheng Lu,Hong Tang,Lvnan Yan,Yong Zeng,Bo Li,Jiayin Yang,Wentao Wang,Hong Wu,Mingqing Xu,Zheyu Chen,Changli Lu,Chuan Li,Wei Peng,Xiaoyun Zhang.Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus[J].Hepatobiliary Surgery and Nutrition,2018,7(5):353-371. 被引量:44
  • 3Shi, Ming,Chen, Ji-An,Lin, Xiao-Jun,Guo, Rong-Ping,Yuan, Yun-Fei,Chen, Min-Shan,Zhang, Ya-Qi,Li, Jin-Qing.Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China[J].World Journal of Gastroenterology,2010,16(2):264-269. 被引量:37
  • 4Xue-Shuai Wan,Yi-Yao Xu,Jun-Yan Qian,Xiao-Bo Yang,An-Qiang Wang,Lian He,Hai-Tao Zhao,Xin-Ting Sang.Intraductal papillary neoplasm of the bile duct[J].World Journal of Gastroenterology,2013,19(46):8595-8604. 被引量:20
  • 5陈孝平,吴在德,裘法祖.肝癌切除联合脾切除治疗肝癌合并肝硬化、脾功能亢进[J].中华外科杂志,2005,43(7):442-446. 被引量:61
  • 6The general rules for the clinical and pathological study of primary liver cancer[J]. The Japanese Journal of Surgery . 1989 (1)
  • 7Jun Akiba,Osamu Nakashima,Satoshi Hattori,Ken Tanikawa,Miki Takenaka,Masamich Nakayama,Reiichiro Kondo,Yoriko Nomura,Keiko Koura,Kousuke Ueda,Sakiko Sanada,Yoshiki Naito,Rin Yamaguchi,Hirohisa Yano.Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification[J].The American Journal of Surgical Pathology.2013(4)
  • 8Kwang Cheol Koh,Hyuk Lee,Moon Seok Choi,Joon Hyoek Lee,Seung Woon Paik,Byung Chul Yoo,Jong Chul Rhee,Jae Won Cho,Cheol Keun Park,Hong Joo Kim.Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma[J]. The American Journal of Surgery . 2005 (1)
  • 9Ruoyu Miao,Haitao Luo,Huandi Zhou,Guangbing Li,Dechao Bu,Xiaobo Yang,Xue Zhao,Haohai Zhang,Song Liu,Ying Zhong,Zhen Zou,Yan Zhao,Kuntao Yu,Lian He,Xinting Sang,Shouxian Zhong,Jiefu Huang,Yan Wu,Rebecca A. Miksad,Simon C. Robson,Chengyu Jiang,Yi Zhao,Haitao Zhao.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis[J]. Journal of Hepatology . 2014
  • 10Nakajima T,Kubosawa H,Kondo Y,Konno A,Iwama S.Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation. American journal of clinical pathology . 1988

共引文献541

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部